[1] Division of Reproductive Health (DRH), WHO. Post abortion family planning:a practical guide for program managers [S].Geneva: 1997.[2] 沈洁,高丽丽,张淞文,等.北京市计划生育服务机构重复人工流产妇女避孕意愿调查[J].中国计划生育学杂志,2012,20(8):525-529.[3] 中华医学会计划生育学分会.人工流产后计划生育服务指南[J].中华妇产科杂志,2011,46(4):319-321.[4] Kathryn K, Susheela S, Barbara V, et al. Estimates of contraceptive failure from 2002 national survey of family growth[J].Contraception,2008,77(1):10-21.[5] Vibeke R, Fortunata Y, Siriel M. Medium and longterm adherence to postabortion contraception among women having experienced unsafe induced abortion in Dar es Salaam, Tanzania[J]. BMC Pregnancy Childbirth, 2008, 8:32.[6] Cheng Y, Xu X, Xu J, et al. The need for integrating family planning and postabortion care in China[J]. Int J Gynaecol Obstet, 2008, 103(2):140-143.[7] 程怡民,李颖,郭欣,等.中国重复流产状况和规范化流产后服务的必要性[J].中国实用妇科与产科杂志,2004,20(9):571-573.[8] Madden T, Secura G M, Allsworth J, E et al. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion [J]. Contraception, 2011, 84(6):571-577.[9] Ferreira A L, Souza A I, Lima R A, et al. Choices on contraceptive methods in post-abortion family planning clinic in the northeast Brazil[J]. Reprod Health, 2010, 7:5.[10] Upadhyay U D, Brown B A, Sokoloff A, et al. Contraceptive discontinuation and repeat unintended pregnancy within 1 year after an abortion[J].Contraception,2012, 85(1): 56-62.[11] 吴尚纯.口服避孕药使用的咨询服务[J].中国计划生育学杂志,2008,16(3):191-193.[12] Department of Reproductive Health, WHO. Medical eligibility criteria for contraceptive use[M]. Geneva: Department of Reproductive Health,2009,4:17.[13] Muhn P,Fuhrmann U,Fritzemeier KH,et al. Drospirenone:a novel progestogen with antimineraloeorticoid and antiandrogenie activity[J].Ann N Y Acad Sei,1995,761:311-335.[14] 范光升,卞美璐,程利南,等.新型口服避孕药屈螺酮炔雌醇片的多中心随机对照临床观察[J].中华妇产科杂志,2009,44(1):38-46.[15] 方玉,舒青青,陈洁瑛,等.流产后即时应用新型短效口服避孕药的临床观察[J].中国计划生育学杂志,2011,19(6):354-357.[16] Williamson LM, Parkes A, Wight D, et al. Limits to modern contraceptive use among young women in developing countries: a systematic review of qualitative research[J].Reprod Health, 2009, 6:3.[17] Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives[J].Obstet Gynecol,2009,114(3):616-622.[18] De Leo V, Di Sabatino A, Musacchio M C, et al. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome[J].Contraception,2010, 82(3):276-280.[19] Kumar U, Baraitser P, Morton S, et al. Peri-abortion contraception: a qualitative study of users' experiences[J]. J Fan Plan Repord Health Care, 2004, 30(1):55-56.[20] 乔晓春.中国妇女人工流产状况分析[J].人口研究,2002,26(3): 16-27. |